Literature DB >> 12744810

Behçet's syndrome: an update.

Hasan Yazici1.   

Abstract

The pathogenic mechanisms in Behçet's syndrome are largely unknown. An autoantigen role for human leukocyte antigen B51 has been proposed. The reasons behind the thrombophilia are also not clear. Endothelial pathology could be the main culprit. The recently proposed association between familial Mediterranean fever and Behçet's syndrome might not be well founded. The long-term prognosis is more guarded among the young and among males. However, the disease burns out in many cases. Clinicians are getting better at management, and have better understanding of the old drugs, such as colchicine, and have new and potent drugs like tumor necrosis factor-alpha inhibitors.

Entities:  

Mesh:

Year:  2003        PMID: 12744810     DOI: 10.1007/s11926-003-0066-9

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  37 in total

1.  Identification of alpha-tropomyosin as a target self-antigen in Behçet's syndrome.

Authors:  Felix Mor; Abraham Weinberger; Irun R Cohen
Journal:  Eur J Immunol       Date:  2002-02       Impact factor: 5.532

2.  Gastrointestinal involvement in Behçet's syndrome: a controlled study.

Authors:  S Yurdakul; N Tüzüner; I Yurdakul; V Hamuryudan; H Yazici
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

3.  Activated protein C resistance caused by factor V Arg 506-->Gln mutation has no role in thrombotic manifestations of Behçet's disease.

Authors:  P Lesprit; B Wechsler; J C Piette; L T Du-Boutin; P Godeau; M Alhenc-Gelas; M Aiach
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

4.  Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.

Authors:  Gerard Espinosa; Josep Font; Dolors Tàssies; Antonio Vidaller; Ramon Deulofeu; Alfons López-Soto; Ricard Cervera; Antoni Ordinas; Miguel Ingelmo; Joan-Carles Reverter
Journal:  Am J Med       Date:  2002-01       Impact factor: 4.965

5.  Anti-Saccharomyces cerevisiae antibodies--a novel serologic marker for Behçet's disease.

Authors:  I Krause; Y Monselise; G Milo; A Weinberger
Journal:  Clin Exp Rheumatol       Date:  2002 Jul-Aug       Impact factor: 4.473

Review 6.  Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis.

Authors:  D L Gumucio; A Diaz; P Schaner; N Richards; C Babcock; M Schaller; T Cesena
Journal:  Clin Exp Rheumatol       Date:  2002 Jul-Aug       Impact factor: 4.473

7.  Histopathologic features of erythema nodosum--like lesions in Behçet disease: a comparison with erythema nodosum focusing on the role of vasculitis.

Authors:  B Kim; P E LeBoit
Journal:  Am J Dermatopathol       Date:  2000-10       Impact factor: 1.533

8.  Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis.

Authors:  S Kurhan-Yavuz; H Direskeneli; N Bozkurt; Y Ozyazgan; T Bavbek; H Kazokoglu; E Eksioglu-Demiralp; G Wildner; M Diedrichs-Möhring; T Akoglu
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

9.  Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study.

Authors:  Erkan Alpsoy; Cicek Durusoy; Ertan Yilmaz; Yilmaz Ozgurel; Oya Ermis; Sahin Yazar; Erdal Basaran
Journal:  Arch Dermatol       Date:  2002-04

10.  Coexistence of familial Mediterranean fever with sacroiliitis and Behçet's disease: a rare occurrence.

Authors:  M Birlik; M Tunca; N Hizli; M Soytürk; Y Yeniçerioğlu; M A Ozcan; O El
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

View more
  9 in total

1.  Visual aspects of Behçet's disease.

Authors:  Tulay Kansu; Sibel Kadayifcilar
Journal:  Curr Treat Options Neurol       Date:  2006-01       Impact factor: 3.598

Review 2.  Epidemiology and management of neuropsychiatric disorders in Behçet's syndrome.

Authors:  Rosaria Talarico; Laura Palagini; Anna d'Ascanio; Elena Elefante; Claudia Ferrari; Chiara Stagnaro; Chiara Tani; Angelo Gemignani; Mauro Mauri; Stefano Bombardieri; Marta Mosca
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

3.  Recurrent longitudinal extensive transverse myelitis in a neuro-Behçet syndrome treated with infliximab.

Authors:  Uğur Uygunoğlu; Maarya Pasha; Sabahattin Saip; Aksel Siva
Journal:  J Spinal Cord Med       Date:  2014-03-28       Impact factor: 1.985

Review 4.  Visual aspects of Behçet's disease.

Authors:  Tulay Kansu; Sibel Kadayifcilar
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

Review 5.  Behçet's Syndrome and Nervous System Involvement.

Authors:  Uğur Uygunoğlu; Aksel Siva
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

6.  The frequency of MEFV gene mutations in Behcet's disease and their relation with clinical findings.

Authors:  Ayten Yazici; Ayse Cefle; Hakan Savli
Journal:  Rheumatol Int       Date:  2011-09-08       Impact factor: 2.631

Review 7.  The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis.

Authors:  Aksel Siva; Sabahattin Saip
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

8.  Cerebral Venous Thrombosis in the Mediterranean Area in Adults. Role of Behçet's Disease as an Underlying Cause.

Authors:  N Y Barlas; G Akman-Demir; S Z Bahar
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-10-24       Impact factor: 2.576

9.  Behcet's Disease With Cerebral Artery Infarction Caused by Cerebral Arteritis as an Early Symptom Only With Elevated Interleukin-8.

Authors:  Hao Yin; Yun Song; Meimei Zheng; Ju Han; Jiyou Tang
Journal:  Front Neurol       Date:  2019-10-22       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.